JOSEPH PASQUALE: Open Payments
NPI 1669666756 · RIVERHEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 90 payments from 17 companies in 2025. Trend: 2023 $173 · 2024 $363 · 2025 $1,903
Food & beverage: $1,903
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 26 | $396 |
| ABBVIE INC. | 15 | $344 |
| Incyte Corporation | 12 | $268 |
| Regeneron Healthcare Solutions, Inc. | 7 | $174 |
| GENZYME CORPORATION | 4 | $143 |
| Janssen Biotech, Inc. | 5 | $105 |
| Arcutis Biotherapeutics, Inc. | 3 | $103 |
| Almirall LLC | 4 | $86 |
| UCB, Inc. | 3 | $64 |
| Botanix SB Inc | 3 | $61 |
Products named: SKYRIZI, OPZELURA, ADBRY, DUPIXENT, ANZUPGO, TREMFYA, Zoryve, LIBTAYO.
Industry payments across NY — which companies pay providers there.
